Cyclic peptides as g-protein-coupled receptor antagonists
CA 2463675 C · Owner: Uniquest Pty Limited · Inventors: March, Darren; Taylor, Steve; Shiels, Ian Alexander
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to novel cyclic compounds which have the ability to modulate the activity of G protein-coupled receptors. The compounds preferably act as antagonists. In preferred embodiments the invention provides cyclic , peptidic and peptidomimetic antagonists of C5a receptors which are active , against C5a receptors on polymorphonuclear leukocytes and macrophages. The compounds of the invention are both potent and selective and are useful in , the treatment of a variety of inflammatory conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 17, 2002 and granted August 7, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 17, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 17, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.